Browsing by Author "García Romero, Noemí"

Depósito Digital UFV

Now showing items 1-12 of 12

A New Natural Antimycotic Agent is Effective Against Oropharyngeal Candidiasis: The VIPROCAN Study.
Carrión Navarro, Josefa; Argüelles, Alejandra; Martínez-Gimeno, María Lara; Tovar Lozada, Alejandro; Ayuso Sacido, Ángel; Belda-Iniesta, Cristobal; Arnás-Rodríguez, Mercedes; García Romero, Noemí (The Open Dentistry Journal, 2022)
Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma.
García Romero, Noemí; Palacín Aliana, I.; Madurga Lacalle, Rodrigo; Carrión Navarro, Josefa; Esteban Rubio, S.; Jiménez, B.; Collazo, A.; Pérez Rodríguez, F.; Ortiz de Mendivil, A.; Fernández Carballal, C.; García Duque, s.; Diamantopoulos-Fernández, J.; Belda Iniesta, C.; Prat Acín, R.; Sánchez Gómez, P.; Calvo, E.; Ayuso Sacido, Ángel (BMC Medicine, 2020)
Beyond the Warburg Effect: Oxidative and Glycolytic Phenotypes Coexist within the Metabolic Heterogeneity of Glioblastoma.
Duraj, Tomás; García Romero, Noemí; Carrión Navarro, Josefa; Madurga Lacalle, Rodrigo; Ortiz de Mendivil, Ana; Prat Acin, Ricardo; Garcia Cañamaque, Lina; Ayuso Sacido, Ángel (Cells, 2021)
CD90 como potencial marcador predicitivo para el tratamiento de gliobastoma con dexametasona.
Franco Ezquerro, Laura (2021)
Clinical Utility of Liquid Biopsy-Based Actionable Mutations Detected via ddPCR.
Palacín Ariana, Irina; García Romero, Noemí (Biomedicines, 2021)
Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle.
Duraj, Tomás; Carrión Navarro, Josefa; Seyfried, Thomas N.; García Romero, Noemí; Ayuso Sacido, Ángel (Molecular Metabolism, 2021)
Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion.
García Romero, Noemí; Palacín Aliana, I.; Esteban Rubio, S.; Madurga Lacalle, Rodrigo; Rius Rocabert, Sergio; Carrión Navarro, Josefa; Presa, Jesús; Cuadrado Castano, Sara; Sánchez Gómez, Pilar; García Sastre, Adolfo; Nistal Villan, Estanislao; Ayuso Sacido, Ángel (Cells, 2020)
Normal tissue content impact on the GBM molecular classification.
Madurga Lacalle, Rodrigo; García Romero, Noemí; Jiménez, Beatriz; Collazo, Ana; Pérez Rodríguez, Francisco; Hernández Laín, Aurelio; Fernández Carballal, Carlos; Prat Acín, Ricardo; Zanin, Massimiliano; Menasalvas, Ernestina; Ayuso Sacido, Ángel (Briefings in Bioinformatics, 2021)
Proteomics and metabolomics approach in adult and pediatric glioma diagnostics.
Pienkowski, Tomasz; Kowalczyk, Tomasz; García Romero, Noemí; Ayuso Sacido, Ángel; Ciborowski, Michal (BBA Reviews on Cancer, 2022)
Suppressor of fused associates with dissemination patterns in patients with glioma.
Peris-Celda, María; Carrión Navarro, Josefa; Palacín Aliana, Irina; Sánchez-Gómez, Pilar; Prat Acín, Ricardo; García Romero, Noemí; Ayuso Sacido, Ángel (Frontiers in Oncology, 2022)
The low affinity A2B adenosine receptor enhances migratory and invasive capacity in vitro and angiogenesis in vivo of glioblastoma stem-like cells.
Erices, José I.; Niechi, Ignacio; Uribe-Ojeda, Atenea; Toro, Mª Ángeles; García Romero, Noemí; Carrión Navarro, Josefa; Monago Sánchez, Álvaro; Ayuso Sacido, Ángel; San Martín, Rody; Quezada-Monras, Claudia (Frontiers in Oncology, 2022)
Unravelling glioblastoma heterogeneity by means of single-cell RNA sequencing.
Hernández Martínez, Ana; Madurga Lacalle, Rodrigo; García Romero, Noemí; Ayuso Sacido, Ángel (Cancer Letters, 2022)